Literature DB >> 974609

Hormonal profiles after the menopause.

S Chakravarti, W P Collins, J D Forecast, J R Newton, D H Oram, J W Studd.   

Abstract

The endocrinological changes of the climacteric have been defined by studying the concentrations of follicle-stimulating hormone (FSH), luteinising hormone (LH), androstenedione, testosterone, oestrone, and oestradiol in 60 normal postmenopausal women of different menopausal ages. The women were studied in six groups, according to the number of years since their menopause. One year after the menopause androstenedione, oestrone, and oestradiol concentrations were reduced to about 20% of the values recorded during the early proliferative phase of the menstrual cycle. At the same time the mean concentration of FSH had risen by a factor of 13-4 and that of LH by a factor of 3-0. Concentrations of both gonadotrophins reached a peak of 18-4 and 3-4 times the proliferative phase value respectively after two to three years, and then gradually declined in the next three decades to values that were 40-50% of these maximal levels. Testosterone concentrations remained mostly in the normal range for premenopausal women but were depressed to 60% of these levels two to five years after the menopause, and the mean androstenedione levels showed a significant increase in the same group of women. The concentrations of both oestrone and oestradiol remained consistently low for 10 years after the menopause, but oestradiol concentrations inexplicably increased in the last two decades, with levels at the lower end of normal range for reproductive women in six patients.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 974609      PMCID: PMC1688678          DOI: 10.1136/bmj.2.6039.784

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  20 in total

1.  PLASMA TESTOSTERONE IN THE NORMAL WOMAN.

Authors:  J LOBOTSKY; H I WYSS; E J SEGRE; C W LLOYD
Journal:  J Clin Endocrinol Metab       Date:  1964-12       Impact factor: 5.958

2.  Further studies on radioimmunoassay systems for plasma oestradiol.

Authors:  G J Barnard; J F Hennam; W P Collins
Journal:  J Steroid Biochem       Date:  1975-02       Impact factor: 4.292

3.  Effects of synthetic luteinizing hormone-releasing hormone on plasma levels of luteinizing hormone and follicle-stimulating hormone in man.

Authors:  K Abe; N Nagata; S Saito; K Tanaka; T Kaneko
Journal:  Endocrinol Jpn       Date:  1972-02

4.  Simultaneous radioimmunoassay of testosterone and dihydrotestosterone.

Authors:  J M Barberia; I H Thorneycroft
Journal:  Steroids       Date:  1974-05       Impact factor: 2.668

5.  A cost reductive method for the radioimmunoassay of plasma androstenedione. A comparison of antisera and the effects of chromatography.

Authors:  J F Hennam; W P Collins
Journal:  Acta Endocrinol (Copenh)       Date:  1974-07

6.  Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood.

Authors:  H L Judd; G E Judd; W E Lucas; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1974-12       Impact factor: 5.958

7.  The effect of chlormadinone acetate on progesterone secretion and metabolism.

Authors:  W P Collins; E N Koullapis; I F Sommerville
Journal:  Acta Endocrinol (Copenh)       Date:  1971-10

8.  Estradiol production after ovariectomy for carcinoma of the breast.

Authors:  J J Barlow; K Emerson; B N Saxena
Journal:  N Engl J Med       Date:  1969-03-20       Impact factor: 91.245

9.  The hormonal activity of the postmenopausal ovary.

Authors:  A Vermeulen
Journal:  J Clin Endocrinol Metab       Date:  1976-02       Impact factor: 5.958

10.  Androstenedione production and interconversion rates measured in peripheral blood and studies on the possible site of its conversion to testosterone.

Authors:  R Horton; J F Tait
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

View more
  41 in total

Review 1.  The menopause and hormone replacement therapy.

Authors:  K T Khaw
Journal:  Postgrad Med J       Date:  1992-08       Impact factor: 2.401

Review 2.  The role of gonadotropins in Alzheimer's disease: potential neurodegenerative mechanisms.

Authors:  Anna M Barron; Giuseppe Verdile; Ralph N Martins
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

3.  Identification of a regulatory loop for the synthesis of neurosteroids: a steroidogenic acute regulatory protein-dependent mechanism involving hypothalamic-pituitary-gonadal axis receptors.

Authors:  Sivan Vadakkadath Meethal; Tianbing Liu; Hsien W Chan; Erika Ginsburg; Andrea C Wilson; Danielle N Gray; Richard L Bowen; Barbara K Vonderhaar; Craig S Atwood
Journal:  J Neurochem       Date:  2009-05-29       Impact factor: 5.372

4.  Aging attenuates the pituitary response to gonadotropin-releasing hormone.

Authors:  Natalie D Shaw; Serene S Srouji; Stephanie N Histed; Kristin E McCurnin; Janet E Hall
Journal:  J Clin Endocrinol Metab       Date:  2009-06-23       Impact factor: 5.958

Review 5.  Luteinizing hormone: Evidence for direct action in the CNS.

Authors:  Jeffrey A Blair; Sabina Bhatta; Henry McGee; Gemma Casadesus
Journal:  Horm Behav       Date:  2015-07-12       Impact factor: 3.587

6.  Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.

Authors:  S Chakravarti; W P Collins; M H Thom; J W Studd
Journal:  Br Med J       Date:  1979-04-14

Review 7.  Testosterone physiology in resistance exercise and training: the up-stream regulatory elements.

Authors:  Jakob L Vingren; William J Kraemer; Nicholas A Ratamess; Jeffrey M Anderson; Jeff S Volek; Carl M Maresh
Journal:  Sports Med       Date:  2010-12-01       Impact factor: 11.136

8.  Down-regulation of serum gonadotropins but not estrogen replacement improves cognition in aged-ovariectomized 3xTg AD female mice.

Authors:  Russell Palm; Jaewon Chang; Jeffrey Blair; Yoelvis Garcia-Mesa; Hyoung-Gon Lee; Rudy J Castellani; Mark A Smith; Xiongwei Zhu; Gemma Casadesus
Journal:  J Neurochem       Date:  2014-04-02       Impact factor: 5.372

9.  FSH enhances the proliferation of ovarian cancer cells by activating transient receptor potential channel C3.

Authors:  Xiang Tao; Naiqing Zhao; Hongyan Jin; Zhenbo Zhang; Yintao Liu; Jian Wu; Robert C Bast; Yinhua Yu; Youji Feng
Journal:  Endocr Relat Cancer       Date:  2013-05-30       Impact factor: 5.678

10.  Down-regulation of serum gonadotropins is as effective as estrogen replacement at improving menopause-associated cognitive deficits.

Authors:  Kathryn J Bryan; Joseph C Mudd; Sandy L Richardson; Jaewon Chang; Hyoung-Gon Lee; Xiongwei Zhu; Mark A Smith; Gemma Casadesus
Journal:  J Neurochem       Date:  2009-11-24       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.